TAUNS Laboratories,Inc.(197A) News

Towns <197A.T> Ranks Third in Rising Sell Predictions Among Individual Investors

Individual Investors' Forecasts: TOWNS Ranks 2nd in Rising Sell Predictions

Towns continues to decline after downward revision due to smaller-than-expected infectious disease outbreak

TAUNS Laboratories, Ordinary Profit Forecast for the Fiscal Year Revised Downward by 49%

Notice Concerning Revision of Full-Year Earnings Forecast

Financial Highlights for 2Q ended December 31, 2025 of FY2026

Financial Results for the SIX Months Ended December 31, 2025 (Japanese Accounting Standards)

TAUNS Laboratories, First Half Ordinary Profit Decreases by 52%, Oct-Dec Ordinary Profit Decreases by 5%

Full-Scale Operation Begins at Fujisan Mishima Factory

TAUNS Laboratories, Inc. has Concluded a Capital and Business Alliance Agreement with EMC Healthcare Co., Ltd

Notice Regarding Acquisition of Shares in CLAIRVO TECHNOLOGIES, Inc. (Making it a Subsidiary)

Financial Highlights for 1Q ended September 30, 2025

Financial Results for the Three Months Ended September 30, 2025 (Japanese Accounting Standards)

Notice of Revision of Dividend Forecast

TAUNS Laboratories, Inc. has Concluded a Capital and Business Alliance Agreement with ElectraDx, Inc., an Innovative POCT and OTC Medical Diagnostics

TAUNS Laboratories, Jul-Sep (1Q) Ordinary Profit Decreases by 87%, First Half Dividend Dividend Revised Upward by 8 Yen

Notice of Organizational Change and Personnel Changes

Notice Regarding Formulation of Mid-Term Management Plan

Financial Results for the Fiscal Year Ended June 30, 2025 (Japanese Accounting Standards)

TAUNS Laboratories, 1% Decrease in Ordinary Profit for The Current Fiscal Year